Vascular endothelial growth factor and tumor necrosis factor genes polymorphisms in turkish patients with sarcoidosis;Sarkoidozlu Türk hastalarda vasküler endotelyal büyüme faktörü (VEGF) ve tümör nekroz faktörü (TNF) gen polimorfizmi

Tuberkuloz ve Toraks

Volumn 56, Issue 1, 2008, Pages 5-14

  Seyhan, Cengiz Ekrem ^a   Çetinkaya, Erdoǧan ^a   Günlüoǧlu, Zeki ^a   Altin, Sedat ^a   Yüksel, Vedat ^b   Işsever, Halim ^c  

^a Research Hospital   (Turkey)

^b Burc Genetic Diagnosis Laboratory   (Turkey)

^c ISTANBUL UNIVERSITY   (Turkey)

Author keywords

Genetic polymorphism; Sarcoidosis; TNF; VEGF

Indexed keywords

DNA; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN A;

ADOLESCENT; ADULT; ARTICLE; BLOOD; CASE CONTROL STUDY; CHEMISTRY; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; HUMAN; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; PROGNOSIS; RECURRENT DISEASE; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SARCOIDOSIS; SINGLE NUCLEOTIDE POLYMORPHISM; TURKEY (REPUBLIC);

ADOLESCENT; ADULT; CASE-CONTROL STUDIES; DNA; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE NUCLEOTIDE; PROGNOSIS; RECURRENCE; SARCOIDOSIS; TUMOR NECROSIS FACTOR-ALPHA; TURKEY; VASCULAR ENDOTHELIAL GROWTH FACTOR A; YOUNG ADULT;

EID: 63449096098     PISSN: 04941373     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. McGrath DS, Goh N, Foley PJ, du Bois RM. Sarcoidosis: Genes and microbes-soil or seed? Sarcoidosis Vasc Diffuse Lung Dis 2001; 18: 149-164
2. Luisetti M, Beratta A, Casali L. Genetic aspects in sarcoidosis. Eur Respir J 2000; 16: 768-780
3. Rybicki BA, Major M, Popovich JJ, et al. Racial differences in sarcoidosis incidence: A 5-year study in a health maintenance organization. Am J Epidemiol 1997; 145: 234-241
4. Agostini C, Semenzato G. Cytokines in sarcoidosis. Semin Respir Infect 1998; 13: 184-196
5. Petrek M, Drabek J, Kolek V, et al. CC chemokine receptor gene polymorphism in Czech patients with pulmonary sarcoidosis. Am J Respir Crit Care Med 2000; 58: 293-298
6. Yamaguchi E, Itoh A, Hizawa N, Kawakami Y. The gene polymorphism of tumor necrosis factor-β, but not that of tumor necrosis factor-α, is associated with the prognosis of sarcoidosis. Chest 2001; 119: 753-761
7. Bergeron A, Bonay M, Kambouchner M, et al. Cytokine patterns in tuberculosis and sarcoid granulomas: Correlations with histopathologic features of the granulomatous response. J Immunol 1997; 159: 3034-3043
8. Udalova IA, Richardson A, Denys A, et al. Functional consequences of a polymorphism affecting NF-kappaB p50-p50 binding to the TNF promotor region. Mol Cell Biol 2000; 20: 9113-9119
9. Papaioannou AI, Kostikas K, Kollia P, Gourgoulianis KI. Clinical implications for vascular endothelial growth factor in the lung: Friend or foe? Respir Res 2006; 7: 128
10. Watson CJ, Webb NJ, Bottomley MJ, Brenchley PE. Identification of polymorphism within vascular endothelial growth factor (VEGF) gene: Correlation with variation in VEGF protein production. Cytokine 2000; 12: 1232-1235
11. Renner W, Kotschan S, Hoffmann C, et al. A common 936 C/T mutation in the gene vascular endothelial growth factor is associated with vascular endothelial growth factor plasma levels. J Vasc Res 2000; 37: 443-448
12. Muller-Quernheim J. Sarcoidosis: Immunopathogenetic concepts and their clinical application. Eur Respir J 1998; 12: 716-738
13. Hunninghake GW, Costabel U, Ando M, et al. Statement on sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 1999; 16: 149-173
14. Mori M, Beatty PG, Graves M, et al. HLA gene and haplotype frequencies in the North American population. Transplantation 1997; 64: 1017-1027
15. Rybicki BA, Kirkey KL, Major M, et al. Familial risk ratio of sarcoidosis in African-American sibs and parents. Am J Epidemiol 2001; 153: 188-193
16. Yamaguchi E, Itoh A, Furuya K, et al. Release of tumor necrosis factor-α from human alveolar macrophages is decreased in smokers. Chest 1993; 103: 479-483
17. Cytokine Gene Polymorphism in Human Disease On-Line Database. http://www.pam.bris.ac.uk/services/GAI/cytokine4.htm
18. Seitzer U, Gerdes J, Müller-Quernheim J. Genotyping in the MHC lokus: Potential for defining predictive markers in sarcoidosis. Respir Res 2002; 3: 6
19. Wilson AG, di Giovine FS, Blakemore AI, Duff GW. Single base polymorphism in the human tumour necrosis factor alpha gene detectable by NcoI restriction of PCR product. Hum Mol Genet 1992; 1: 353
20. Kroeger KM, Carville KS, Abraham LJ. The -308 tumour necrosis factor-alpha promotor polymorphism effects transcriptions. Mol Immunol 1997; 34: 391-399
21. Yamaguchi E, Itoh A, Hizawa N, Kawakami Y. The gene polymorphism of tumor necrosis factor-β, but not that of tumor necrosis factor-α, is associated with the prognosis of sarcoidosis. Chest 2001; 119: 753-761
22. Swider C, Schnittger L, Bougunia-Kubik K, et al. TNFalpha and HLA-DR genotyping as potential prognostic markers in pulmonary sarcoidosis. Eur Cytokine Netw 1999; 10: 143-146
23. Ugliolara AM, Turbay D, Pesavento PA, et al. Idendification of three new single nucleotide polymorphism in the human tumour necrosis factor-alpha gene promoter. Tissue Antigenes 1998; 52: 359-362
24. Higuchi T, Seki N, Kamizono S, et al. Polymorphism of the 5'-flanking region of the human tumor necrosis factor- alpha gene in Japanese. Tissue Antigenes 1998; 51: 605-12
25. Grutters JC, Sato H, Pantelidis P, et al. Increased frequency of the uncommon tumor necrosis factor-857T allele in British and Dutch patients with sarcoiddosis. Am J Respir Crit Care Med 2002; 165: 1119-1124
26. Tolnay E, Kuhnen C, Voss B, et al. Expression and lokalization of vascular endothelial growth factor and its receptor flt in pulmonary sarcoidosis. Virchows Arch 1998; 432: 61-65
27. Koyama S, Sato E, Haniuda M, et al. Decreased level of vascular endothelial growth factor in bronchoalveolar lavage fluid of normal smokers and patient with pulmonary fibrosis. Am J Respir Crit Care Med 2002; 166: 382-385
28. Sekiya M, Ohwada A, Miura K, et al. Serum vascular endothelial growth factor as a possible prognostic indicator of sarcoidosis. Lung 2003; 181: 259-265
29. Hu YF, Luscher B, Admon A. Transcription factor AP-4 contains multiple dimerization domains that regulate dimer specifity. Genes Dev 1990; 4: 1741-1752
30. Morohashi K, Takada T, Omori K, et al. Vascular endothelial growth factor gene polymorphism in Japanese patients with sarcoidosis. Chest 2003; 123: 1520-1526.